Killer coma: the evolving story of sleeping sickness treatment.
出版信息
Lancet. 2010 Jan 9;375(9709):93. doi: 10.1016/S0140-6736(10)60029-3.
Abstract
摘要
相似文献
1
Killer coma: the evolving story of sleeping sickness treatment.致命昏迷：昏睡病治疗的演变历程
Lancet. 2010 Jan 9;375(9709):93. doi: 10.1016/S0140-6736(10)60029-3.
2
African sleeping sickness.非洲昏睡病
Br J Hosp Med (Lond). 2016 Oct;77(10):C157-C160. doi: 10.12968/hmed.2016.77.10.C157.
3
The treatment of human African trypanosomiasis.人类非洲锥虫病的治疗。
Adv Parasitol. 1994;33:1-47. doi: 10.1016/s0065-308x(08)60410-8.
4
NECT trial: more than a small victory over sleeping sickness.NECT试验：对昏睡病而言，这可不只是一个小胜利。
Lancet. 2009 Jul 4;374(9683):7-9. doi: 10.1016/S0140-6736(09)61163-6. Epub 2009 Jun 24.
5
Human African trypanosomiasis.非洲人类锥虫病。
Lancet. 2010 Jan 9;375(9709):148-59. doi: 10.1016/S0140-6736(09)60829-1. Epub 2009 Oct 14.
6
[Agents for the treatment of African sleeping sickness. Those developed in the last century].[治疗非洲昏睡病的药物。上个世纪研发的药物]
Pharm Unserer Zeit. 2009;38(6):552-8. doi: 10.1002/pauz.200900344.
7
Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.硝呋替莫-依氟鸟氨酸联合疗法治疗布氏冈比亚锥虫二期昏睡病：刚果的一项随机临床试验
Clin Infect Dis. 2007 Dec 1;45(11):1435-42. doi: 10.1086/522982. Epub 2007 Oct 22.
8
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.硝呋替莫-依氟鸟氨酸联合疗法治疗第二阶段冈比亚布氏锥虫病：一项多中心、随机、III期、非劣效性试验
Lancet. 2009 Jul 4;374(9683):56-64. doi: 10.1016/S0140-6736(09)61117-X. Epub 2009 Jun 24.
9
Drug resistance in human African trypanosomiasis.人体非洲锥虫病的耐药性。
Future Microbiol. 2011 Sep;6(9):1037-47. doi: 10.2217/fmb.11.88.
10
[The return of sleeping sickness in an epidemic form: international action for drugs].[昏睡病以流行形式卷土重来：药物方面的国际行动]
Ned Tijdschr Geneeskd. 2002 Dec 28;146(52):2527-30.
Zotero 插件